Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2013, Article ID 957947, 11 pages
http://dx.doi.org/10.1155/2013/957947
Research Article

The Amelioration of N-Acetyl-p-Benzoquinone Imine Toxicity by Ginsenoside Rg3: The Role of Nrf2-Mediated Detoxification and Mrp1/Mrp3 Transports

Department of Pharmacology, College of Oriental Medicine, Dongguk University, Kyungju 780-714, Republic of Korea

Received 2 February 2013; Accepted 22 April 2013

Academic Editor: Mi-Kyoung Kwak

Copyright © 2013 Sang Il Gum and Min Kyung Cho. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. K. Kim and J. H. Park, “Trends in ginseng research in 2010,” Journal of Ginseng Research, vol. 35, no. 4, pp. 389–398, 2011. View at Google Scholar
  2. K. W. Leung and A. S. Wong, “Pharmacology of ginsenosides: a literature review,” Chinese Medicine, vol. 5, article 20, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. S. I. Gum, S. J. Jo, S. H. Ahn et al., “The potent protective effect of wild ginseng (Panax ginseng C.A. Meyer) against benzo[α]pyrene-induced toxicity through metabolic regulation of CYP1A1 and GSTs,” Journal of Ethnopharmacology, vol. 112, no. 3, pp. 568–576, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. S. I. Gum and M. K. Cho, “Korean red ginseng extract prevents APAP-induced hepatotoxicity through metabolic enzyme regulation: the role of ginsenoside Rg3, a protopanaxadiol,” Liver International, 2013. View at Publisher · View at Google Scholar
  5. P. Y. K. Yue, N. K. Mak, Y. K. Cheng et al., “Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides,” Chinese Medicine, vol. 2, article 6, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Sengupta, S. A. Toh, L. A. Sellers et al., “Modulating angiogenesis: the yin and the yang in ginseng,” Circulation, vol. 110, no. 10, pp. 1219–1225, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. Q. J. Chen, M. Z. Zhang, and L. X. Wang, “Gensenoside Rg3 inhibits hypoxia-induced VEGF expression in human cancer cells,” Cellular Physiology and Biochemistry, vol. 26, no. 6, pp. 849–858, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. T. T. Hien, N. D. Kim, Y. R. Pokharel, S. J. Oh, M. Y. Lee, and K. W. Kang, “Ginsenoside Rg3 increases nitric oxide production via increases in phosphorylation and expression of endothelial nitric oxide synthase: essential roles of estrogen receptor-dependent PI3-kinase and AMP-activated protein kinase,” Toxicology and Applied Pharmacology, vol. 246, no. 3, pp. 171–183, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. N. D. Kim, E. M. Kim, K. W. Kang, M. K. Cho, S. Y. Choi, and S. G. Kim, “Ginsenoside Rg3 inhibits phenylephrine-induced vascular contraction through induction of nitric oxide synthase,” The British Journal of Pharmacology, vol. 140, no. 4, pp. 661–670, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Moore, H. Thor, G. Moore, S. Nelson, P. Moldéus, and S. Orrenius, “The toxicity of acetaminophen and N-acetyl-p-benzoquinone imine in isolated hepatocytes is associated with thiol depletion and increased cytosolic Ca2+,” The Journal of Biological Chemistry, vol. 260, no. 24, pp. 13035–13040, 1985. View at Google Scholar · View at Scopus
  11. A. Enomoto, K. Itoh, E. Nagayoshi et al., “High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes,” Toxicological Sciences, vol. 59, no. 1, pp. 169–177, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Z. Kanter, “Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning,” The American Journal of Health-System Pharmacy, vol. 63, no. 19, pp. 1821–1827, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. A. H. Dawson, D. A. Henry, and J. McEwen, “Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning,” Medical Journal of Australia, vol. 150, no. 6, pp. 329–331, 1989. View at Google Scholar · View at Scopus
  14. S. A. Reisman, I. I. Csanaky, L. M. Aleksunes, and C. D. Klaassen, “Altered disposition of acetaminophen in Nrf2-null and keap1-knockdown mice,” Toxicological Sciences, vol. 109, no. 1, pp. 31–40, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Yang, Y. Chen, E. Johansson et al., “Interaction between the catalytic and modifier subunits of glutamate-cysteine ligase,” Biochemical Pharmacology, vol. 74, no. 2, pp. 372–381, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Ramos-Gomez, M. K. Kwak, P. M. Dolan et al., “Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 6, pp. 3410–3415, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. L. M. Aleksunes, A. L. Slitt, J. M. Maher et al., “Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2,” Toxicology and Applied Pharmacology, vol. 226, no. 1, pp. 74–83, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. M. Maher, M. Z. Dieter, L. M. Aleksunes et al., “Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway,” Hepatology, vol. 46, no. 5, pp. 1597–1610, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. S. S. M. Villanueva, M. L. Ruiz, C. I. Ghanem, M. G. Luquita, V. A. Catania, and A. D. Mottino, “Hepatic synthesis and urinary elimination of acetaminophen glucuronide are exacerbated in bile duct-ligated rats,” Drug Metabolism and Disposition, vol. 36, no. 3, pp. 475–480, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. C. I. Ghanem, M. L. Ruiz, S. S. M. Villanueva et al., “Effect of repeated administration with subtoxic doses of acetaminophen to rats on enterohepatic recirculation of a subsequent toxic dose,” Biochemical Pharmacology, vol. 77, no. 10, pp. 1621–1628, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. M. K. Kwak, N. Wakabayashi, J. L. Greenlaw, M. Yamamoto, and T. W. Kensler, “Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway,” Molecular and Cellular Biology, vol. 23, no. 23, pp. 8786–8794, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. M. K. Cho, W. D. Kim, S. H. Ki et al., “Role of Gα12 and Gα13 as novel switches for the activity of Nrf2, a key antioxidative transcription factor,” Molecular and Cellular Biology, vol. 27, no. 17, pp. 6195–6208, 2007. View at Publisher · View at Google Scholar
  23. M. K. Cho and S. G. Kim, “Hepatocyte growth factor activates CCAAT enhancer binding protein and cell replication via PI3-kinase pathway,” Hepatology, vol. 37, no. 3, pp. 686–695, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. O. W. Griffith, “Biologic and pharmacologic regulation of mammalian glutathione synthesis,” Free Radical Biology and Medicine, vol. 27, no. 9-10, pp. 922–935, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Hayashi, H. Suzuki, K. Itoh, M. Yamamoto, and Y. Sugiyama, “Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts,” Biochemical and Biophysical Research Communications, vol. 310, no. 3, pp. 824–829, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Y. Poon, H. H. Kwok, P. Y. Yue et al., “Cytoprotective effect of 20S-Rg3 on benzo[a]pyrene-induced DNA damage,” Drug Metabolism and Disposition, vol. 40, no. 1, pp. 120–129, 2012. View at Publisher · View at Google Scholar
  27. C. Cheung, A. M. Yu, J. M. Ward et al., “The CYP2E1-humanized transgenic mouse: role of CYP2E1 in acetaminophen hepatotoxicity,” Drug Metabolism and Disposition, vol. 33, no. 3, pp. 449–457, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Keays, P. M. Harrison, J. A. Wendon et al., “Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial,” The British Medical Journal, vol. 303, no. 6809, pp. 1026–1029, 1991. View at Google Scholar · View at Scopus
  29. A. M. Moyer, B. L. Fridley, G. D. Jenkins et al., “Acetaminophen-NAPQI hepatotoxicity: a cell line model system genome-wide association study,” Toxicological Sciences, vol. 120, no. 1, pp. 33–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. A. M. Lucas, G. Hennig, P. K. Dominick, H. E. Whiteley, J. C. Roberts, and S. D. Cohen, “Ribose cysteine protects against acetaminophen-induced hepatic and renal toxicity,” Toxicologic Pathology, vol. 28, no. 5, pp. 697–704, 2000. View at Google Scholar · View at Scopus
  31. C. E. P. Goldring, N. R. Kitteringham, R. Elsby et al., “Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 mice,” Hepatology, vol. 39, no. 5, pp. 1267–1276, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. M. K. Kwak, T. W. Kensler, and R. A. Casero Jr., “Induction of phase 2 enzymes by serum oxidized polyamines through activation of Nrf2: effect of the polyamine metabolite acrolein,” Biochemical and Biophysical Research Communications, vol. 305, no. 3, pp. 662–670, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. S. G. Kim and S. J. Lee, “PI3K, RSK, and mTOR signal networks for the GST gene regulation,” Toxicological Sciences, vol. 96, no. 2, pp. 206–213, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Okada, J. Shoda, K. Taguchi et al., “Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice,” The American Journal of Physiology, vol. 295, no. 4, pp. G735–G747, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Y. Song, D. H. Kim, E. H. Kim et al., “Multidrug resistance-associated protein 1 mediates 15-deoxy-Delta(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells,” Chemical Research in Toxicology, vol. 24, no. 8, pp. 1231–1241, 2011. View at Publisher · View at Google Scholar
  36. H. R. Kast, B. Goodwin, P. T. Tarr et al., “Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor,” The Journal of Biological Chemistry, vol. 277, no. 4, pp. 2908–2915, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Yamamoto, M. Kyo, T. Kamiya et al., “Predictive base substitution rules that determine the binding and transcriptional specificity of Maf recognition elements,” Genes to Cells, vol. 11, no. 6, pp. 575–591, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Xiong, K. C. Turner, E. S. Ward, P. L. M. Jansen, and K. L. R. Brouwer, “Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR- rats1,” Journal of Pharmacology and Experimental Therapeutics, vol. 295, no. 2, pp. 512–518, 2000. View at Google Scholar · View at Scopus
  39. V. M. Silva, M. S. Thibodeau, C. Chen, and J. E. Manautou, “Transport deficient (TR-) hyperbilirubinemic rats are resistant to acetaminophen hepatotoxicity,” Biochemical Pharmacology, vol. 70, no. 12, pp. 1832–1839, 2005. View at Publisher · View at Google Scholar · View at Scopus